Trastuzumab Deruxtecan Significantly Reduces Human Epidermal Growth Factor Receptor 2-Positive Pancreatic Metastasis from Advanced Breast Cancer: A Case Report
Our patient with HER2-positive pancreatic metastasis achieved CR with marked shrinkage using T-DXd and a progression-free survival of 14 months. FNB should be performed to diagnose possible pancreatic metastases if a pancreatic tumor is detected during breast cancer treatment.
Authors
- Mai Hamada-Nishimoto
- Noriko Senda (ORCID: https://orcid.org/0000-0002-5836-7556)
- Shigeru Tsuyuki (ORCID: https://orcid.org/0000-0003-1701-3820)
- Toshiki Shiozaki
- Takaki Sakurai (ORCID: https://orcid.org/0000-0002-1179-039X)
- Yookija Kang
- Hirotake Fujii
- Tadao Tanaka
- Rino Tanida
Institutions
- Osaka Red Cross Hospital (JP)
Publication Details
- Journal
- Surgical Case Reports
- Published
- 2025-01-01
- DOI
- https://doi.org/10.70352/scrj.cr.25-0304
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00